Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetic assay

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 5, 1999, Pages 380-383

  Palomino, J C ^a   Portaels, F ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0032751736     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00015025     Document Type: Article

References (20)

1. 1. Raviglione ML, Snider DE, Kochi A: Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. Journal of the American Medical Association (1995) 237:220-226
2. 2. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Lambregts-van Weezenbeek CS, Kim SJ, Chaulet P, Nunn P: Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. New England Journal of Medicine (1998) 338:1641-1649
3. 3. Young DB: New tools for tuberculosis control: do we really need them? International Journal of Tuberculosis and Lung Disease (1997) 1:193-195
4. 4. Kent PT, Kubica GP : Public health mycobacteriology: a guide for the level III laboratory. U.S. Department of Health and Human Services, Atlanta (1985) pp 159-184
5. 5. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA : Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bulletin of the World Health Organization (1969) 41:21-43
6. 6. Roberts GD, Goodman NL, Heifets L, Larsh HW, Lindner TH, McClatchy JK, McGinnis MR, Siddiqi SH, Wright P: Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear positive specimens. Journal of Clinical Microbiology (1983) 18:689-696
7. 7. Nilsson LE, Hoffner SE, Ansehn S: Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrobial Agents and Chemotherapy (1988) 32:1208-1212
8. 8. Norden MA, Kurzynski TA, Bownds SE, Callister SM, Schell RF: Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. Journal of Clinical Microbiology (1995) 33:1231-1237
9. 9. Wanger A, Mills K: Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using E test. Journal of Clinical Microbiology (1996) 34:1672-1676
10. 10. Walters SB, Hanna BA: Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube method. Journal of Clinical Microbiology (1996) 34:1565-1567
11. 11. Garza-Gonzalez E, Guerrero-Olazaran M, Tijerina-Menchaca R, Viader-Salvado JM: Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis. Journal of Clinical Microbiology (1997) 35:1287-1289
12. 3-thymidine incorporation assay. Journal of Immunological Methods (1994) 170:211-224
13. 13. Page B, Mage M, Noel C: A new fluorometric assay for cytoxicity measurements in vitro. International Journal of Oncology (1993) 3:473-476
14. 14. Novak SM, Hindler J, Bruckner DA: Reliability of two novel methods, Alamar and E test, for detection of methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology (1993) 31:3056-3057
15. 15. Zabransky RJ, Dinuzzo AR, Woods GL: Detection of vancomycin resistance in enterococci by the Alamar MIC system. Journal of Clinical Microbiology (1995) 33:791-793
16. 16. Pfaller MA, Barry AL: Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. Journal of Clinical Microbiology (1994) 32:1992-1996
17. 17. Yajko DM, Madej JJ, Lancaster MV, Sanders CA, Cawthon VL, Gee B, Babst A, Hadley WK: Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. Journal of Clinical Microbiology (1995) 33:2324-2327
18. 18. Collins L, Franzblau SG: Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Journal of Clinical Microbiology (1997) 41:1004-1009
19. 19. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH: Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar blue assay. Journal of Clinical Microbiology (1998) 36:362-366
20. 20. Laszlo A, Rahman M, Raviglione M, Bustreo F: Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. International Journal of Tuberculosis and Lung Disease (1997) 1:231-238